TIDES Europe 2026 Exhibitors
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
98 organizations exhibit at TIDES Europe 2026 — 96 suppliers and service providers and 2 drug developers. 25 of them also present on the scientific program, with 36 presentations between them. Most represented: Bachem (5 on the program), PolyPeptide Group (4 on the program), Agilent Technologies (2 on the program). 98 of them have their own page in this guide. As of Sep 25, 2026.
Focus
Top represented
Showing 1–30 of 98 organizations
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Bachem Bubendorf, Switzerland | |
Contract development and manufacturing organization for peptide and oligonucleotide active pharmaceutical ingredients, from research quantities to commercial scale. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 15:00–15:30 A Mild and Sustainable Platform for Disulfide Bond Formation in Peptide Manufacturing Using Dehydroascorbic Acid Using an oxidised form of vitamin C instead of harsh chemicals to form the sulfur bridges that hold many peptide drugs in shape. Talk Wed Nov 4 14:30–15:00 Beyond Packed Beds: Advancing Scalable Oligonucleotide Manufacturing Through Stirred-Bed Technology Building oligonucleotides in a continuously stirred reactor rather than a packed column, so reagents mix evenly and batches can reach ton scale. Talk Wed Nov 4 16:15–16:45 Dapiglutide: From Lab to Large Scale Manufacture through Innovative Peptide Process Development How process changes in making the peptide drug dapiglutide raised its overall yield from about 20% to over 60%. Talk Wed Nov 4 11:50–12:20 Digital Manufacturing in Practice: Enabling Efficient and Compliant Large-scale Production Running large-scale production on digital records and automation, and what that changed for output, consistency and the ability to spot process problems. CMC & Manufacturing Talk Thu Nov 5 08:00–08:05 |
PolyPeptide Group Baar, Switzerland | |
Contract development and manufacturing organization for peptide and oligonucleotide APIs, from clinical to commercial scale. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 09:05–09:35 Strategies for Manufacturing of Long and Complex Peptides: Technical Considerations and Case Studies Ways to make long, sticky peptides at scale by mixing solid-support and solution methods and cutting solvent use, with real examples. Talk Wed Nov 4 14:00–14:30 Case Studies of Pre-clinical Development and IND Acceleration for Peptides Case studies on lining up early peptide process work, manufacturing plans and safety testing so a drug reaches first clinical trials sooner. |
Agilent Technologies Santa Clara, CA | |
Makes liquid chromatography, mass spectrometry and other analytical instruments, and manufactures oligonucleotide active pharmaceutical ingredients under contract. | Booth Exhibiting at Booth 317 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 16:45–17:15 Analytical Method Validation Across the Oligonucleotide Lifecycle How a contract manufacturer validates the tests used to check oligonucleotide drugs, from raw materials to release, without slowing development. Talk Wed Nov 4 11:50–12:20 Integrated Analytical Workflows for Synthetic Peptide Development: From Peptide Separation to Sequence Confirmation Combining separation, mass measurement and software to confirm a synthetic peptide's sequence, purity and starting materials at every stage. PeptidesCMC & Manufacturing |
Almac Craigavon, United Kingdom | |
Drug development services for small molecules and peptides, including analytical testing, API supply, radiolabelling, formulation and solid-state services. | Booth Exhibiting at Booth 227 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 11:00–11:30 Individualised Cancer Vaccines: Developing a High-throughput cGMP Peptide Manufacturing Philosophy How to make twenty different peptides to clinical quality in twenty days for one patient's personalised cancer vaccine, then do it again. Talk Thu Nov 5 10:45–11:25 Part 1: siRELIS: A Convergent Enzymatic Ligation Strategy for siRNA Manufacturing; Part 2: Enzyme Development for Oligonucleotide Therapeutics Manufacturing Using engineered joining enzymes to assemble siRNA from short building blocks, and what scaling that approach taught two companies. |
Asymchem Tianjin, China | |
Contract development and manufacturing organization for small molecules, oligonucleotides and peptides, with flow chemistry and enzymatic process capabilities. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 12:15–12:45 Innovating Oligonucleotide Production: Enzymatic Fragment Ligation for siRNA Joining short RNA fragments with enzymes in water instead of standard solid-phase steps, for purer siRNA at lower cost and larger scale. OligonucleotidesCMC & Manufacturing Talk Thu Nov 5 07:30–08:00 Advancing TIDES with Flow Chemistry How running peptide and oligonucleotide chemistry as a continuous flowing stream tightens control, improves safety and cuts waste. CMC & Manufacturing |
Axolabs Kulmbach, Germany | |
Oligonucleotide contract research and manufacturing organization offering discovery, preclinical, analytical and GMP manufacturing services. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 09:00–12:00 CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact Which early manufacturing and quality decisions set what an oligonucleotide drug costs to produce, and when in development they should be taken. Talk Wed Nov 4 13:25–13:55 From Development Candidate Nomination to First-in-Human: Accelerating Oligonucleotide Development Through Integrated Strategies What it took to move a sugar-tagged siRNA candidate from selection to its first human trial on a tight schedule. OligonucleotidesCMC & Manufacturing |
Codexis Redwood City, CA | |
Engineers enzymes and the ECO Synthesis enzymatic platform for manufacturing siRNA and other RNA therapeutics. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 15:00–15:30 Advancing siRNA Manufacturing with User-Defined Phosphorothioate Stereochemistry An all-enzyme process that lets makers choose the three-dimensional arrangement of each sulfur linkage in a siRNA drug. Talk Wed Nov 4 09:45–09:55 Sustainable Scale in RNAi Manufacturing How an enzyme-based process run in water instead of organic solvents changes the waste and climate footprint of making gene-silencing drugs. OligonucleotidesCMC & Manufacturing |
Contract development and manufacturing organization for peptides, oligonucleotides, lipids and complex APIs, with integrated drug product supply. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 14:30–15:00 Accelerate Timeline to Start PhI: Phase Appropriate Development and Integrated Drug Product Supply Running peptide drug substance and finished-product development side by side to reach safety testing and the first human trial sooner. Talk Thu Nov 5 13:55–14:00 |
Supplies HPLC and BioLC columns, preparative chromatography media and process systems, including continuous chromatography, for oligonucleotide and peptide purification. | Booth Exhibiting at Booth 414 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 11:30–12:00 Innovations in Preparative Purification of Synthetic Peptides How better column materials and automation have made large-scale peptide purification cheaper, easing supply of GLP-1 drugs and insulin. |
Ajinomoto Bio-Pharma Services San Diego, CA | |
Contract development and manufacturing organization for oligonucleotides, peptides and biologics, offering AJIPHASE liquid-phase synthesis technology. | Booth Exhibiting at Booth 410 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 13:25–13:55 Addressing the Next Scale of Oligonucleotide Manufacturing: CMC Guided Transition from Solid Phase Synthesis to AJIPHASE® and Chemical Enzymatic siRNA Production Why one maker plans to move oligonucleotide production from solid-phase to liquid-phase chemistry, and how enzymes could join fragments at larger scale. OligonucleotidesCMC & Manufacturing |
Supplies purification and fluid management technologies and pathogen safety testing services for manufacturers of biotherapeutics and pharmaceuticals. | Booth Exhibiting at Booth 216 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 13:25–13:55 OCELOT®: The Open, Unified Software Platform for Modern Oligo Manufacturing How one control software runs the machines used to make and purify oligonucleotides, shown with data from real production runs. OligonucleotidesCMC & Manufacturing |
Spatial biology tools built on RNAscope in situ hybridization and the COMET system: reagents, instruments and software for RNA and protein detection. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 12:50–13:10 Spatially Resolving RNA Therapeutics in Heterogenous Organs: RNAscope to Correlate Biodistribution and Efficacy at Single-Cell Resolution How a tissue staining method shows which individual cells take up an RNA drug and whether it changes gene activity there. OligonucleotidesDiscovery & Clinical |
Bruker Billerica, MA | |
Makes mass spectrometry, NMR and other analytical instruments used to characterize peptides, oligonucleotides and other drug molecules. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 11:50–12:20 Peptide Diversity and Therapeutics by NMR: Scalable Methods from Early Sequences to Drug Candidates How nuclear magnetic resonance can check peptide structure at scale, from short test peptides to a cancer drug candidate. PeptidesCMC & Manufacturing |
Catalent Somerset, NJ | |
Contract development and manufacturing organization for drug products, including oral delivery technologies and injectable formulation and fill-finish. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 12:30–12:50 Advancing Beyond Injections: Technologies Driving Oral Delivery of Peptides Ways to get peptide drugs absorbed when swallowed rather than injected, using fatty carriers, slow-release capsules and the lining of the mouth. PeptidesDiscovery & Clinical |
Supplies pharmaceutical excipients, lipids for nucleic acid delivery, adjuvants and other ingredients for drug formulation and manufacturing. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 10:05–10:35 Optimising GAP Peptide Synthesis for Tirzepatide Fragments How anchoring a growing peptide in a chosen solvent improved the yield and purity of fragments for a GLP-1 drug. |
Cytiva Marlborough, MA | |
Supplies tools and technologies for developing, manufacturing and delivering therapeutics. | Booth Exhibiting at Booth 210 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 11:50–12:20 An Engineer’s View: Process Intensification for Sustainability An engineer's view of how changing equipment and process steps could make solid-phase oligonucleotide synthesis more productive and less polluting. OligonucleotidesCMC & Manufacturing |
DuPont Wilmington, DE | |
Supplies purification media, including polymeric reverse-phase chromatography resins, used to purify peptides and oligonucleotides. | Booth Exhibiting at Booth 229 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 11:50–12:20 GLP-1 Receptor Agonist Purification Combining Polymeric and Silica Reverse Phase Media How purifying the GLP-1 drug liraglutide on two different column materials, alternating acidic and basic conditions, raised both purity and yield. PeptidesCMC & Manufacturing |
Makes spray dryers and other process equipment for drying and stabilizing pharmaceutical materials. | Booth Exhibiting at Booth 114 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 13:25–13:55 Continuous Downstream Process to Stabilize Oligonucleotides How a drying step keeps oligonucleotides stable in a continuous production line that must cope with water and other solvents. OligonucleotidesCMC & Manufacturing |
Supplies nucleosides, phosphoramidites and other raw materials for oligonucleotide and mRNA manufacturing, plus chemoenzymatic siRNA manufacturing. | Booth Exhibiting at Booth 427 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 13:25–13:55 Meeting Future Demand with Scalable Chemoenzymatic Approaches - Advances in High-Purity siRNA and sgRNA Manufacturing How engineered enzymes can stitch short chemical pieces into long RNA, making gene-editing guide RNA and silencing RNA purer and cheaper. OligonucleotidesCMC & Manufacturing |
Nitto Avecia Milford, Massachusetts | |
Contract developer and manufacturer of oligonucleotide APIs, from process development through commercial GMP production. | Booth Exhibiting at Booth 102 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 16:15–16:45 |
OmniAb Emeryville, California | |
Licenses antibody discovery platforms built on transgenic animals to drug developers. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 09:55–10:05 OmniUltra™: A Dual Modality In Vivo Discovery Platform for Novel Human Antibodies and Structured Peptides How antibodies carrying unusually long loops can reach deep pockets on a target, and how those loops work alone as small peptides. PeptidesDiscovery & Clinical |
SCIEX Framingham, Massachusetts | |
Makes mass spectrometry and capillary electrophoresis systems and software for characterizing oligonucleotides and other biomolecules. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 12:15–12:45 From Purity to Structural Insight: Advanced CE and LC-MS Solutions for Oligonucleotide Characterization New capillary electrophoresis and mass spectrometry methods that separate oligonucleotides differing by one base and spot rare impurities. OligonucleotidesCMC & Manufacturing |
Thermo Fisher Scientific Waltham, Massachusetts | |
Supplies phosphoramidites and other oligonucleotide and RNA building blocks, purification and analytical products, and contract manufacturing services. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 15:40–15:50 From Building Blocks to Therapeutics: Thermo Fisher’s Integrated RNA & Oligonucleotide Supply Chain The raw materials, chemical building blocks, enzymes and early-stage production one supplier offers for RNA and oligonucleotide medicines. OligonucleotidesCMC & Manufacturing |
Supplies chromatography resins and columns, including TOYOPEARL and TSKgel, for purifying and analysing oligonucleotides, peptides and other biomolecules. | Booth Exhibiting at Booth 128 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 11:50–12:20 From Purification to Characterization: Chromatographic Approaches for Nucleic Acid-based Therapeutic Modalities How the same chromatography toolbox can both purify nucleic acid medicines and measure what is actually in them during development. OligonucleotidesCMC & Manufacturing |
WuXi TIDES Shanghai, China | |
WuXi AppTec's integrated contract development and manufacturing platform for oligonucleotides, peptides and related conjugates. | Booth Exhibiting at Booth 704 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 07:30–08:00 Overcoming Scale-Up Barriers: Ensuring Robust CMC for Next-Gen Peptide and Oligonucleotide Drugs Which manufacturing and quality choices decide whether a complex looped or chemically linked peptide drug can still be made at full scale. CMC & Manufacturing |
ADS Biotec Omaha, NE | |
Makes HPLC purification columns, buffers and WAVE systems for nucleic acid separation, including RNASep columns for mRNA purification. | Booth Exhibiting at Booth 106 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
Belgian analytical contract service provider supporting development of small molecules, biologics, biosimilars and cell and gene therapies. | Booth Exhibiting at Booth 96 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
Chinese pharmaceutical company producing active pharmaceutical ingredients and offering contract development and manufacturing services. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
Apextide Hangzhou, China | |
Contract research, development and manufacturing organization for oligonucleotides and peptides, from discovery and CMC development through GMP supply. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
cGMP manufacturer of peptide APIs for pharmaceutical and veterinary use, from milligrams to multi-kilogram batches, including single-patient personalized peptides. | Booth Exhibiting at Booth 237 Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
Instantly find 20 buyers from TIDES Europe 2026 exhibitors
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse TIDES Europe 2026 by
Organization type
Focus
Exhibit hall
- Exhibitors 98
Everyone
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction